190 related articles for article (PubMed ID: 6250392)
1. Acute and chronic systemic and pulmonary hemodynamic effects of angiotensin converting enzyme inhibition with captopril in hypertensive patients.
Fagard R; Amery A; Reybrouck T; Lijnen P; Billiet L
Am J Cardiol; 1980 Aug; 46(2):295-300. PubMed ID: 6250392
[No Abstract] [Full Text] [Related]
2. Hemodynamic response to captopril at rest and during exercise in hypertensive patients.
Fagard R; Lijnen P; Amery A
Am J Cardiol; 1982 Apr; 49(6):1569-71. PubMed ID: 7041600
[No Abstract] [Full Text] [Related]
3. Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor.
Ader R; Chatterjee K; Ports T; Brundage B; Hiramatsu B; Parmley W
Circulation; 1980 May; 61(5):931-7. PubMed ID: 6244906
[TBL] [Abstract][Full Text] [Related]
4. Acute and chronic effects of the angiotensin-converting enzyme inhibitor captopril in severe hypertension.
Havelka J; Vetter H; Studer A; Greminger P; Lüscher T; Wollnik S; Siegenthaler W; Vetter W
Am J Cardiol; 1982 Apr; 49(6):1467-74. PubMed ID: 6280477
[No Abstract] [Full Text] [Related]
5. Hemodynamic effects of captopril in essential hypertension, renovascular hypertension and cardiac failure: correlations with short- and long-term effects on plasma renin.
Wenting GJ; de Bruyn JH; Man in't Veld AJ; Woittiez AJ; Derkx FH; Schalekamp MA
Am J Cardiol; 1982 Apr; 49(6):1453-9. PubMed ID: 6803562
[No Abstract] [Full Text] [Related]
6. Effect of converting enzyme and angiotensin II inhibitors in chronic one kidney bipolar ligated hypertension.
Loyke HF
Pharmacol Res Commun; 1981 May; 13(5):501-9. PubMed ID: 6270704
[No Abstract] [Full Text] [Related]
7. Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure.
Levine TB; Franciosa JA; Cohn JN
Circulation; 1980 Jul; 62(1):35-41. PubMed ID: 6247102
[No Abstract] [Full Text] [Related]
8. [Inhibition of the angiotensin I converting enzyme with SQ-14225 (captopril) in the medical treatment of severe renovascular hypertension].
Martínez Amenós A; Caralps A; Rama H; Sarrias X; Alsina J
Rev Clin Esp; 1981 Sep; 162(6):265-8. PubMed ID: 7036249
[No Abstract] [Full Text] [Related]
9. Captopril, an orally active angiotensin I converting enzyme inhibitor in the treatment of renovascular and essential hypertension.
Holtzman E; Rosenthal T; Stern N; Knecht A; Yaron A
Isr J Med Sci; 1982 May; 18(5):597-602. PubMed ID: 6284678
[TBL] [Abstract][Full Text] [Related]
10. Effects of converting enzyme inhibitor on hepatic blood flow in man.
Crossley IR; Bihari D; Gimson AE; Westaby D; Richardson PJ; Williams R
Am J Med; 1984 May; 76(5B):62-5. PubMed ID: 6328986
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic effects of captopril in one-kidney, one clip hypertensive rabbits.
Kogure M; Ichikawa S; Sakamaki T; Matsuo H; Tajima Y; Fujita H; Murata K
Clin Exp Hypertens A; 1984; 6(5):1035-54. PubMed ID: 6375906
[TBL] [Abstract][Full Text] [Related]
12. Participation of the renin system in treatment-resistant hypertension as measured by acute blockade of the angiotensin converting enzyme.
Weber MA; Drayer JI; Priest RT; Chen TC
Am J Nephrol; 1982; 2(1):6-11. PubMed ID: 6295161
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic and clinical significance of the pulmonary vascular response to long-term captopril therapy in patients with severe chronic heart failure.
Packer M; Lee WH; Medina N; Yushak M
J Am Coll Cardiol; 1985 Sep; 6(3):635-45. PubMed ID: 2993397
[TBL] [Abstract][Full Text] [Related]
14. Haemodynamic effects of captopril in hypertensive patients: comparison with saralasin.
Fagard R; Amery A; Lijnen P; Reybrouck T
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():131s-134s. PubMed ID: 396066
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of an angiotensin-II analog and a converting enzyme inhibitor.
Fagard RH; Amery AK; Lijnen PJ; Reybrouck TM
Kidney Int; 1980 May; 17(5):647-53. PubMed ID: 6249956
[TBL] [Abstract][Full Text] [Related]
16. Regulation of renal hemodynamics and glomerular filtration in patients with renovascular hypertension during converting enzyme inhibition with captopril.
Textor SC; Tarazi RC; Novick AC; Bravo EL; Fouad FM
Am J Med; 1984 May; 76(5B):29-37. PubMed ID: 6328984
[TBL] [Abstract][Full Text] [Related]
17. [Progressive reversible kidney insufficiency after blood pressure reduction with captopril].
Kindler J; Konrads A; Meurer KA; Sieberth HG
Internist (Berl); 1981 Jun; 22(6):360-3. PubMed ID: 6265394
[No Abstract] [Full Text] [Related]
18. Quantitative differences in the hemodynamic effects of captopril and nitroprusside in severe chronic heart failure.
Packer M; Meller J; Medina N; Yushak M
Am J Cardiol; 1983 Jan; 51(1):183-8. PubMed ID: 6336876
[TBL] [Abstract][Full Text] [Related]
19. Effect of captopril on renal hemodynamics in the treatment of resistant renal hypertension.
Björck S; Herlitz H; Nyberg G; Granerus G; Aurell M
Hypertension; 1983; 5(5 Pt 2):III152-3. PubMed ID: 6354931
[TBL] [Abstract][Full Text] [Related]
20. Constrasts and similarities of acute hemodynamic responses to specific antagonism of angiotensin II ([Sar1, Thr8] A II) and to inhibition of converting enzyme (captopril).
Fouad FM; Ceimo JM; Tarazi RC; Bravo EL
Circulation; 1980 Jan; 61(1):163-9. PubMed ID: 6985575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
